Assessment of LI-RADS Efficacy in the Classification of Hepatocellular Carcinoma and Benign Liver Nodules Using DCE-MRI Features and ADC MRI
Abstract
The Liver Imaging Reporting and Data System (LI-RADS) is a widely utilized tool for classifying liver lesions, particularly in patients at risk for hepatocellular carcinoma (HCC). This study aims to assess the efficacy of LI-RADS in distinguishing between HCC and benign liver nodules by leveraging dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) features and apparent diffusion coefficient (ADC) values derived from MRI. Between October 2023 and March 2024, 43 patients with suspected HCC underwent MRI evaluation, including DCE-MRI and DWI sequences. The diagnostic performance of various MRI sequences was analyzed, focusing on their ability to differentiate HCC from benign lesions. The diagnostic efficacy of DCE-MRI and ADC in differentiation was evaluated using statistical analyses, such as t-tests and receiver operating characteristic (ROC) curve analysis. SPSS VER 16 was used to analyze the collected data. The study findings reveal that the DCE-MRI arterial phase demonstrated perfect diagnostic accuracy with an area under the curve (AUC) of 1.00, achieving 100% sensitivity and specificity. T2-weighted imaging also exhibited diagnostic solid performance, with an AUC of 0.801, while ADC values from DWI sequences showed limited efficacy in differentiating HCC from benign lesions (AUC=0.512). These findings indicate that DCE-MRI significantly enhances the accuracy of LI-RADS in classifying HCC versus benign liver nodules. This study highlights the importance of incorporating advanced imaging features into LI-RADS to improve the diagnostic precision of liver lesion evaluation in clinical practice.
2. Dhanasekaran R, Limaye A, Cabrera R. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med-Evid Res 2012:19-37.
3. White DL, Kanwal F, Jiao L, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatocellular Carcinoma: Diagnosis and Treatment 2016:3-24.
4. Gomez-Quiroz LE, Roman S. Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in Mexico. Ann Hepatol 2022; 27:100649.
5. Ramakrishna G, Rastogi A, Trehanpati N, Sen B, Khosla R, Sarin SK. From cirrhosis to hepatocellular carcinoma: new molecular insights on inflammation and cellular senescence. Liver cancer 2013;2:367-83.
6. Al-Muftah M, Al-Ejeh F. Cancer incidence and mortality estimates in Arab countries in 2018: A GLOBOCAN data analysis. Cancer Epidemiol Biomarkers Prev 2023;32:1738-46.
7. De Muzio F, Grassi F, Dell’Aversana F, Fusco R, Danti G, Flammia F, et al. A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls. Diagnostics 2022;12:1655.
8. Ismail M, Lalani T, Kielar A, Hong C, Yacoub J, Lim C, et al. Lessons learned: strategies for implementing and the ongoing use of LI-RADS in your practice. Abdom Radiol 2024:1-3.
9. Kim YY, Choi JY, Sirlin CB, An C, Kim MJ. Pitfalls and problems to be solved in the diagnostic CT/MRI Liver Imaging Reporting and Data System (LI-RADS). Eur Radiol 2019; 29:1124-32.
10. Elsayes KM, Fowler KJ, Chernyak V, Elmohr MM, Kielar AZ, Hecht E, et al. User and system pitfalls in liver imaging with LI‐RADS. J Magn Reson Imaging 2019;50:1673-86.
11. Rodgers SK, Fetzer DT, Gabriel H, Seow JH, Choi HH, Maturen KE, et al. Role of US LI-RADS in the LI-RADS Algorithm. Radiogr a Rev Publ Radiol Soc North Am Inc 2019;39:690–708.
12. Terzi E, Giamperoli A, Iavarone M, Leoni S, De Bonis L, Granito A, et al. Prognosis of single early-stage hepatocellular carcinoma (HCC) with CEUS inconclusive imaging (LI-RADS LR-3 and LR-4) is No better than typical HCC (LR-5). Cancers 2022;14:336.
13. Razek AA, El-Serougy LG, Saleh GA, Abd El-Wahab R, Shabana W. Interobserver agreement of magnetic resonance imaging of liver imaging reporting and data system version 2018. J Comput Assist Tomogr 2020;44:118-23.
14. Basha MA, Refaat R, Mohammad FF, Khamis ME, El-Maghraby AM, El Sammak AA, et al. The utility of diffusion-weighted imaging in improving the sensitivity of LI-RADS classification of small hepatic observations suspected of malignancy. Abdom Radiol 2019; 44: 1773-1784.
15. Hicks RM, Yee J, Ohliger MA, Weinstein S, Kao J, Ikram NS, et al. Comparison of diffusion-weighted imaging and T2-weighted single shot fast spin-echo: Implications for LI-RADS characterization of hepatocellular carcinoma. Magn Reson Imaging 2016; 34: 915-921.
16. Nam SJ, Yu JS, Cho ES, Kim JH, Chung JJ. High-flow haemangiomas versus hypervascular hepatocellular carcinoma showing “pseudo-washout” on gadoxetic acid-enhanced hepatic MRI: value of diffusion-weighted imaging in the differential diagnosis of small lesions. Clin Radiol 2017; 72: 247-254.
17. Lewis S, Peti S, Hectors SJ, King M, Rosen A, Kamath A, et al. Volumetric quantitative histogram analysis using diffusion-weighted magnetic resonance imaging to differentiate HCC from other primary liver cancers. Abdom Radiol 2019; 44: 912-922.
Files | ||
Issue | Vol 63 No 2 (2025) | |
Section | Original Articles | |
Keywords | ||
LI-RADS efficacy DCE-MRI Apparent diffusion coefficient Hepatocellular carcinoma |
Rights and permissions | |
![]() |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |